Importantly, the present study suggests that miR146a-5p-modifed UC-MSCs enhance protection against renal injury in DN through facilitating M2 macrophage polarization by targeting TRAF6-STAT1 signaling, which may offer new therapeutic approaches for DN currently lacking effective treatment. Here, TRAF6 is linked to liver dysplastic nodule.